Skip to main content

Table 4 Test characteristics at different faecal haemoglobin concentration cut-offs by sex

From: Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?

 

Positive predictive valuea (%)

Positivity rate (%)

Colorectal cancer detection rate (‰)

Advanced neoplasia detection rate (‰)

Cut-off μg Hb/g faeces

Men

Women

p value

Men

Women

p value

Men

Women

p value

Men

Women

p value

20

52.8 (51.9–53.7)

32.9 (31.9–34.0)

< 0.0001

8.3 (8.1–8.4)

4.8 (4.7–4.9)

< 0.0001

5.2 (4.8–5.6)

2.2 (2.0–2.4)

< 0.0001

44.0 (42.9–45.1)

15.9 (15.2–16.5)

< 0.0001

25

56.0 (55.0–57.0)

36.5 (35.2–37.7)

< 0.0001

6.9 (6.8–7.1)

3.8 (3.7–3.9)

< 0.0001

4.9 (4.5–5.3)

2.1 (1.9–2.3)

< 0.0001

39.0 (38.0–40.1)

13.9 (13.3–14.5)

< 0.0001

30

57.4 (56.3–58.4)

38.3 (37.0–39.6)

< 0.0001

6.2 (6.1–6.4)

3.3 (3.2–3.4)

< 0.0001

4.7 (4.3–5.1)

2.0 (1.8–2.2)

< 0.0001

36.0 (35.0–37.0)

12.8 (12.3–13.4)

< 0.0001

35

58.6 (57.5–59.7)

39.2 (37.8–40.5)

< 0.0001

5.7 (5.6–5.8)

3.0 (2.9–3.1)

< 0.0001

4.6 (4.3–5.0)

1.9 (1.7–2.2)

< 0.0001

33.8 (32.8–34.7)

11.9 (11.3–12.4)

< 0.0001

40

59.8 (58.7–61.0)

40.6 (39.1–42.0)

< 0.0001

5.3 (5.2–5.4)

2.7 (2.6–2.8)

< 0.0001

4.5 (4.1–4.8)

1.9 (1.6–2.1)

< 0.0001

31.9 (31.0–32.8)

11.2 (10.7–11.7)

< 0.0001

50

61.5 (60.3–62.6)

42.2 (40.6–43.7)

< 0.0001

4.6 (4.5–4.7)

2.4 (2.3–2.5)

< 0.0001

4.3 (3.9–4.6)

1.7 (1.5–2.0)

< 0.0001

28.7 (27.8–29.6)

10.2 (9.7–10.7)

< 0.0001

60

62.7 (61.5–64.0)

43.3 (41.7–45.0)

< 0.0001

4.2 (4.1–4.3)

2.1 (2.0–2.2)

< 0.0001

4.1 (3.8–4.4)

1.7 (1.5–1.9)

< 0.0001

26.5 (25.7–27.4)

9.3 (8.8–9.8)

< 0.0001

  1. aPPV applies for AN: defined as advanced adenoma (AA) plus colorectal cancer (CRC). Advanced adenomas: adenomas ≥10 mm, ≥3 adenoma, adenoma with a villous component (i.e., tubulovillous or villous adenoma) or adenomas with severe/high-grade dysplasia